By Christopher Norton ( June 27, 2011, 8:45 PM EDT) -- Mylan Laboratories Inc. asked the U.S. Supreme Court in mid-June to review a $76 million antitrust verdict brought against it over licensing agreements for two anti-anxiety medications, claiming the plaintiffs, four health insurance companies, cannot show diversity of citizenship to establish subject matter jurisdiction....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.